ALT
Price:
$2.61
Market Cap:
$230.35M
Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for obesity and various liver diseases. Its primary investigational drug, pemvidutide (proposed INN, previously known as ALT-801), operates as a GLP-1/glucagon dual receptor agonist. This compound is currently undergoing Phase 1b clinical trials, exploring its efficacy in treating both obesity and non-alcoholic steatohepatitis (NASH). Additionally, Altimmune is advancing HepTcell, an immunotherapeutic candidate, through Phase 2 clinical trials. This therapy is designed for individuals suffering from chronic hepatitis B virus infection. The enterprise, initially named Vaxin Inc., officially adopted ...[Read more]
Industry
Biotechnology
IPO Date
2017-05-26
Stock Exchange
NASDAQ
Ticker
ALT
According to Altimmune, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 168.60M. This represents a change of -39.60% compared to the average of 279.14M of the last 4 quarters.
The mean historical Enterprise Value of Altimmune, Inc. over the last ten years is 216.24M. The current 168.60M Enterprise Value has changed 7.70% with respect to the historical average. Over the past ten years (40 quarters), ALT's Enterprise Value was at its highest in in the December 2022 quarter at 712.97M. The Enterprise Value was at its lowest in in the December 2016 quarter at -122976004.80.
Average
216.24M
Median
182.24M
Minimum
-122323459.60
Maximum
661.97M
Discovering the peaks and valleys of Altimmune, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 895.55%
Maximum Annual Enterprise Value = 661.97M
Minimum Annual Increase = -978.60%
Minimum Annual Enterprise Value = -122323459.60
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 309.98M | -34.97% |
| 2024 | 476.69M | 2.61% |
| 2023 | 464.58M | -29.82% |
| 2022 | 661.97M | 249.52% |
| 2021 | 189.39M | 8.17% |
| 2020 | 175.09M | 895.55% |
| 2019 | 17.59M | -164.25% |
| 2018 | -27373036.08 | -263.30% |
| 2017 | 16.76M | -113.70% |
| 2016 | -122323459.60 | -978.60% |
The current Enterprise Value of Altimmune, Inc. (ALT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
417.09M
5-year avg
420.52M
10-year avg
216.24M
Altimmune, Inc.’s Enterprise Value is less than DBV Technologies S.A. (366.68M), less than Annexon, Inc. (413.52M), greater than Korro Bio, Inc. (96.75M), greater than enGene Holdings Inc. (79.79M), greater than Larimar Therapeutics, Inc. (122.82M), less than Aura Biosciences, Inc. (343.72M), less than Amarin Corporation plc (189.73M), less than Alto Neuroscience, Inc. (495.40M), less than LB Pharmaceuticals Inc Common Stock (497.78M), less than AC Immune S.A. (172.37M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 366.68M | $416.60M | |
| 413.52M | $563.29M | |
| 96.75M | $115.56M | |
| 79.79M | $82.94M | |
| 122.82M | $296.96M | |
| 343.72M | $411.52M | |
| 189.73M | $315.21M | |
| 495.40M | $753.47M | |
| 497.78M | $814.99M | |
| 172.37M | $235.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Altimmune, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Altimmune, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Altimmune, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Altimmune, Inc. (ALT)?
What is the 3-year average Enterprise Value for Altimmune, Inc. (ALT)?
What is the 5-year average Enterprise Value for Altimmune, Inc. (ALT)?
How does the current Enterprise Value for Altimmune, Inc. (ALT) compare to its historical average?